+1 700 888 1234
Effingerstrasse 40 3008 Bern Switzerland
Being well aware of the importance of continuing generating evidence that will benefit the overall lung cancer community and the patient advocacy groups in particular, LuCE aims to produce reports and position papers by following a consistent methodology based on:
The aim of this report is to identify barriers and areas of improvement
to enhance the lung cancer care pathway. Even with differences in the
structure and delivery of care across Europe, the findings of this
report stress the need for person-centred models that develops and
improves partnerships between individuals and their healthcare
providers. It also highlights the continual need for improvement in both
the access and delivery of care for people impacted by lung cancer.
This is an annual initiative led by lung cancer patient organisations, with the purpose of raising awareness regarding the main challenges faced by people impacted by this disease across Europe.
Lung cancer is the biggest cancer killer worldwide. In Europe, there are 470,000 new diagnoses and more than 380,000 lung cancer deaths every year1.
This 2020 LuCE Position Paper covers data regarding access to lung cancer treatment and diagnosis, in order to raise awareness about access inequities among patients in European countries.
This report is an annual initiative led by lung cancer patient organisations, with the purpose of raising awareness about the biggest challenges that patients across Europe face.
Welcome to the 3rd edition of the LuCE Report. This report is an annual initiative led by lung cancer patient organisations, with the purpose of raising awareness about the biggest challenges that patients across Europe face.
After the 1st LuCE Report in 2016, in which we highlighted the main challenges in lung cancer in Europe from the patient perspective, we launch this 2nd Report to deepen our research on one of our main worries: disparities on access across Europe.
Thousands of people are diagnosed with lung cancer in Europe every year and sadly this is the biggest cancer killer. Lung cancer is one of the major public health problems today and it requires a global solution.
With an estimated incidence of over 449 000 cases per year, lung cancer is one of the most common
malignancies in Europe.